VIVE

Viveve Medical Inc. (VIVE) | Rumor.io

Viveve Medical

VIVE

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)100%

Price to earnings ratio-0

Market capitalization2.1K

Earnings per share-1.33

Dividend yield (TTM)—

Revenue (annual)6.4M

Net income (annual)-22M

Social

What share of all stock conversation is about VIVE?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Jan 19

$VIVE is down 10.90% at $0.13, with 1M shares traded in the last 11 minutes.
The company's stock was delisted from NASDAQ and moved to the OTC market on January 19, 2023.
Some investors have reported mixed results from trading $VIVE, with some experiencing losses and others expressing uncertainty about the stock's future.

Generated by AI

Sentiment

Of the messages about VIVE that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	100%
Bearish	—	—	—	0%

Bullish· Jun 24

$VIVE has the potential for a 100% move due to its low float and history of price runs.
The company's recent price increase is expected to continue, with some analysts predicting a breakout above $1.20.
$VIVE's strong momentum and lack of short float make it a promising investment opportunity, with some traders already seeing a 45.9% gain.

Bearish· Jan 18

$VIVE is in a downtrend, with the RSI indicator exiting the overbought zone.
The stock's performance has been poor, with some investors expressing frustration and disappointment.
The company's ticker has been associated with significant losses, with some investors joking about wanting to lose money.

Generated by AI

Topics

Of the messages about VIVE that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	—
Announcements	—	—	—	—
Controversies	—	—	—	—
Earnings	—	—	—	—
Macro	—	—	—	—
Technical Analysis	—	—	—	—

Announcements· Jan 18

Viveve Medical, Inc. may be a candidate for a buyout or merger due to its accumulated deficit and continued cash generation from sales of the Viveve system.
The company received a notice from the exchange regarding potential delisting due to failure to meet continued listing rules or standards.
Viveve Medical, Inc. has filed an SEC Form 8-K regarding a notice of delisting or failure to satisfy a continued listing rule or standard, and a transfer of listing.

Technical Analysis· Jan 21

$VIVE has formed a double bottom pattern, with a potential break above 1.18 and continuation into the next day.
The stock has a bullish MACD cross on the 5-minute chart, indicating a potential move higher.
A break above 1.32 with volume could lead to a move towards 1.50 or higher, while a failure to break above 1.32 could lead to a move lower.

Generated by AI

Community

Of the messages about VIVE, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	0%
Newcomers	—	—	—	100%

Regulars· Jan 18

The regulars are focused on the price action of $VIVE, with a notable 6.2% gain so far, and are discussing the importance of trailing stops with EMAs to protect profits.
The SEC filing of 8-K for $VIVE has been released, detailing a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, with the company's stock facing potential delisting.
The regulars are also analyzing the Form 8-K for $VIVE, which reports on costs associated with exit or disposal activities, as the company's Board of Directors approved a reduction of the Company’s working capital.

Newcomers· Jan 18

The newcomer is focused on a recent binary play that didn't pan out, leading to the sale of all VIVE shares.
They express a preference for lower-risk investments, citing NVOS as a potential option.
The newcomer is waiting for news or developments that could improve their investment prospects.

Generated by AI

Also Discussed

Investors talking about VIVE also mention

#	Name	Attention
1	GHSI - Guardion Health Sciences, Inc.	——
2	OBLN - Obalon Therapeutics, Inc.	——
3	BIMI - BIMI International Medical Inc.	——
4	Legacy Education Inc.LGCY	0%new
5	ASLN - ASLAN Pharmaceuticals Limited	——
6	YTEN - Yield10 Bioscience, Inc.	——
7	Xenetic Biosciences, Inc.XBIO	0%new
8	NovaBay Pharmaceuticals, Inc.NBY	0%0
9	TBLT - ToughBuilt Industries, Inc.	——
10	Alpha Metallurgical Resources, Inc.AMR	0%0

Viveve Medical Inc.

Healthcare
Medical Devices

Viveve Medical Inc. specializes in the design, development, manufacturing, and marketing of medical devices primarily focused on women's health. Its flagship product, the Viveve System, employs Cryogen-cooled Monopolar Radiofrequency technology for non-invasive treatments addressing vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. This innovative medical technology plays a significant role in enhancing women's well-being by offering low-risk, high-reward procedures. Viveve Medical Inc. operates across a global network, including the Americas, Europe, and Asia-Pacific regions, making it a notable player in the healthcare sector, particularly within the medical devices industry.

Website

Location

Building B

Englewood, CO, 80112

United States

Social

What share of all stock conversation is about VIVE?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Jan 19

$VIVE is down 10.90% at $0.13, with 1M shares traded in the last 11 minutes.
The company's stock was delisted from NASDAQ and moved to the OTC market on January 19, 2023.
Some investors have reported mixed results from trading $VIVE, with some experiencing losses and others expressing uncertainty about the stock's future.

Generated by AI

Sentiment

Of the messages about VIVE that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	100%
Bearish	—	—	—	0%

Bullish· Jun 24

$VIVE has the potential for a 100% move due to its low float and history of price runs.
The company's recent price increase is expected to continue, with some analysts predicting a breakout above $1.20.
$VIVE's strong momentum and lack of short float make it a promising investment opportunity, with some traders already seeing a 45.9% gain.

Bearish· Jan 18

$VIVE is in a downtrend, with the RSI indicator exiting the overbought zone.
The stock's performance has been poor, with some investors expressing frustration and disappointment.
The company's ticker has been associated with significant losses, with some investors joking about wanting to lose money.

Generated by AI

Topics

Of the messages about VIVE that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	—
Announcements	—	—	—	—
Controversies	—	—	—	—
Earnings	—	—	—	—
Macro	—	—	—	—
Technical Analysis	—	—	—	—

Announcements· Jan 18

Viveve Medical, Inc. may be a candidate for a buyout or merger due to its accumulated deficit and continued cash generation from sales of the Viveve system.
The company received a notice from the exchange regarding potential delisting due to failure to meet continued listing rules or standards.
Viveve Medical, Inc. has filed an SEC Form 8-K regarding a notice of delisting or failure to satisfy a continued listing rule or standard, and a transfer of listing.

Technical Analysis· Jan 21

$VIVE has formed a double bottom pattern, with a potential break above 1.18 and continuation into the next day.
The stock has a bullish MACD cross on the 5-minute chart, indicating a potential move higher.
A break above 1.32 with volume could lead to a move towards 1.50 or higher, while a failure to break above 1.32 could lead to a move lower.

Generated by AI

Community

Of the messages about VIVE, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	0%
Newcomers	—	—	—	100%

Regulars· Jan 18

The regulars are focused on the price action of $VIVE, with a notable 6.2% gain so far, and are discussing the importance of trailing stops with EMAs to protect profits.
The SEC filing of 8-K for $VIVE has been released, detailing a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, with the company's stock facing potential delisting.
The regulars are also analyzing the Form 8-K for $VIVE, which reports on costs associated with exit or disposal activities, as the company's Board of Directors approved a reduction of the Company’s working capital.

Newcomers· Jan 18

The newcomer is focused on a recent binary play that didn't pan out, leading to the sale of all VIVE shares.
They express a preference for lower-risk investments, citing NVOS as a potential option.
The newcomer is waiting for news or developments that could improve their investment prospects.

Generated by AI

Viveve Medical

Social

Jan 19

Sentiment

Bullish· Jun 24

Bearish· Jan 18

Topics

Announcements· Jan 18

Technical Analysis· Jan 21

Community

Regulars· Jan 18

Newcomers· Jan 18

Also Discussed

Viveve Medical Inc.

Company Information

Location

Also Discussed

Social

Jan 19

Sentiment

Bullish· Jun 24

Bearish· Jan 18

Topics

Announcements· Jan 18

Technical Analysis· Jan 21

Community

Regulars· Jan 18

Newcomers· Jan 18